163 related articles for article (PubMed ID: 20187769)
1. Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.
Sachdeva RK; Wanchu A; Bagga R; Malla N; Sharma M
J Interferon Cytokine Res; 2010 May; 30(5):299-310. PubMed ID: 20187769
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
[TBL] [Abstract][Full Text] [Related]
3. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
[TBL] [Abstract][Full Text] [Related]
5. Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.
Burton CT; Hardy GA; Sullivan AK; Nelson MR; Gazzard B; Gotch FM; Imami N
Clin Exp Immunol; 2002 Nov; 130(2):286-92. PubMed ID: 12390317
[TBL] [Abstract][Full Text] [Related]
6. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
Boulassel MR; Smith GH; Edwardes MD; Young M; Klein M; Gilmore N; Macleod J; Leblanc R; René P; Allan J; Lalonde RG; Routy JP
HIV Med; 2005 Jul; 6(4):268-77. PubMed ID: 16011532
[TBL] [Abstract][Full Text] [Related]
7. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.
Herold BC; Keller MJ; Shi Q; Hoover DR; Carpenter CA; Huber A; Parikh UM; Agnew KJ; Minkoff H; Colie C; Nowicki MJ; DʼSouza G; Watts DH; Anastos K
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):485-93. PubMed ID: 23591635
[TBL] [Abstract][Full Text] [Related]
8. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption.
Barqasho B; Nowak P; Tjernlund A; Kinloch S; Goh LE; Lampe F; Fisher M; Andersson J; Sönnerborg A;
HIV Med; 2009 Feb; 10(2):94-102. PubMed ID: 19200172
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
[TBL] [Abstract][Full Text] [Related]
11. Genital inflammation and the risk of HIV acquisition in women.
Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
[TBL] [Abstract][Full Text] [Related]
12. Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators.
Spear GT; Sha BE; Saarloos MN; Benson CA; Rydman R; Massad LS; Gilmore R; Landay AL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):454-9. PubMed ID: 9715841
[TBL] [Abstract][Full Text] [Related]
13. Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles.
Gargiulo AR; Fichorova RN; Politch JA; Hill JA; Anderson DJ
Fertil Steril; 2004 Oct; 82 Suppl 3():1226-34. PubMed ID: 15474100
[TBL] [Abstract][Full Text] [Related]
14. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.
Wasmuth JC; Nischalke HD; Jütte A; Fätkenheuer G; Salzberger B; Sauerbruch T; Spengler U; Rockstroh JK; Dumoulin FL
Antiviral Res; 2004 Mar; 61(3):207-12. PubMed ID: 15168802
[TBL] [Abstract][Full Text] [Related]
15. Cytokines and HIV-1: interactions and clinical implications.
Kedzierska K; Crowe SM
Antivir Chem Chemother; 2001 May; 12(3):133-50. PubMed ID: 12959322
[TBL] [Abstract][Full Text] [Related]
16. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
17. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
18. Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children.
Lambert JS; Machado ES; Watson DC; Sill AM; Lim JK; Charurat M; Cunha SM; Afonso AO; Oliviera RH; Tanuri A; DeVico AL
Pediatr Infect Dis J; 2007 Oct; 26(10):935-44. PubMed ID: 17901800
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
[TBL] [Abstract][Full Text] [Related]
20. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
